معرفی
Anjana Pillai is a Professor in the Department of Medicine-Gastroenterology at the University of Chicago. Her academic career focuses on hepatology, liver transplantation, and hepatocellular carcinoma (HCC) research. She completed her MD at the University of Miami School of Medicine, followed by internal medicine training at the University of Illinois Chicago and gastroenterology/hepatology fellowships at the Cleveland Clinic and Northwestern Memorial Hospital.
- Education:
- MD: University of Miami School of Medicine (FL)
- Internal Medicine Residency: University of Illinois Chicago
- Gastroenterology and Hepatology Fellowship: Cleveland Clinic
- Transplant Hepatology Fellowship: Northwestern Memorial Hospital
Her research interests include:
- Advances in HCC treatment (systemic and locoregional therapies)
- Liver transplantation outcomes and policy
- Immunotherapy in hepatocellular carcinoma
- Ethical considerations in solid organ transplantation
- Gender and racial disparities in liver transplant access
Recent work examines:
- Combination therapies (e.g., Yttrium-90 radioembolization with immunotherapy)
- Impact of antiviral therapy on HCC recurrence
- Noninvasive diagnostic models for liver conditions
Publications focus on optimizing HCC surveillance strategies, improving transplant candidate selection, and addressing challenges in transplant hepatology workforce training.
۰مقاله منتشرشده
